-
1 Comment
Eurobio Scientific Société anonyme is currently in a long term uptrend where the price is trading 12.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.4.
Based on the above factors, Eurobio Scientific Société anonyme gets an overall score of 2/5.
CurrencyCode | EUR |
---|---|
ISIN | FR0013240934 |
Sector | Healthcare |
Industry | Medical Devices |
Exchange | PA |
Beta | 0.4 |
---|---|
Market Cap | 250M |
PE Ratio | 40.19 |
Target Price | 30 |
Dividend Yield | None |
Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, a molecular test for the surveillance of heart-transplant patients; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients' immune status against tetanus; and EBX molecular biology family, which includes a range of tests for identifying various pathogens responsible for infectious diseases and assessing the magnitude of the infection. The company also develops other diagnostic products using molecular biology. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ALERS.PA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025